Long-Term Outcomes of the Ovation Stent Graft System Investigational Device Exemption Trial for Endovascular Abdominal Aortic Aneurysm Repair

The objective of this study was to report the 5-year outcomes of the Food and Drug Administration investigational device exemption clinical trial of endovascular aneurysm repair (EVAR) with the Ovation (Endologix, Irvine, Calif) stent graft for elective treatment of abdominal aortic aneurysm (AAA).

https://www.jvascsurg.org/article/S0741-5214(19)31561-7/fulltext?rss=yes

Source: Journal of Vascular Surgery - August 21, 2019 Category: Surgery Authors: Andrew Barleben, Asma Mathlouthi, Manish Mehta, Thomas Nolte, Francisco Valdes, Mahmoud B. Malas Tags: Abstract from the 2019 Western Vascular Society Annual Meeting Source Type: research